SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Fat Tissue Is Sensitive To Irradiation, Institut Louis Bugnard Study
December 30, 2008
 · 
1 min read
Drug Development
Potential Therapy For Congenital Muscular Dystrophy, University of Nevada School of Medicine Study
December 30, 2008
 · 
1 min read
Drug Development
Potential New Molecule To Prevent Inflammation, Sao Paulo State University Study
December 30, 2008
 · 
1 min read
Drug Development
Molecule That Targets Brain Tumors Identified, University of California, Davis (UCD) Cancer Center Study
December 30, 2008
 · 
1 min read
Drug Development
Processed Food May Fuel Lung Tumors: Seoul National University Study
December 30, 2008
 · 
1 min read
Drug Development
Brain Birth Defects Successfully Reversed Through Stem Cell Therapy, Hebrew University of Jerusalem Study
December 29, 2008
 · 
1 min read
Drug Development
University of Southern California Researchers Derive First Embryonic Stem Cells From Rats
December 29, 2008
 · 
1 min read
Drug Development
Georgia State University Study First To Pinpoint Why Analgesic Drugs May Be Less Potent In Females Than In Males
December 23, 2008
 · 
1 min read
Drug Development
Hormones Boost Frequency of Women’s Migraine With Aura, Massachusetts General Hospital Study
December 23, 2008
 · 
1 min read
Drug Development
Drug Shields Mice From Chronic Lung Disease, Johns Hopkins University School of Medicine Study
December 23, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Akeso Publishes Preclinical Results of TIGIT monoclonal antibody（AK127）at the American Association for Cancer Research (AACR) 2022 Annual Meeting
April 14, 2022
 · 
1 min read
Drug Development
AACR 2022 | Ascentage Pharma Presents Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022
April 13, 2022
 · 
12 min read
Drug Development
New data show HOOKIPA’s arenaviral immunotherapies induce potent T cell responses in novel combinations and against tumor self-antigens
April 13, 2022
 · 
6 min read
Drug Development
Kineta Unveils New Preclinical Data on its Anti-CD27 Agonist Lead Antibodies at AACR 2022
April 13, 2022
 · 
3 min read
Drug Development
OncoNano Medicine Announces Positive Preclinical Data for ONM-501 at AACR 2022 Annual Meeting
April 13, 2022
 · 
3 min read
Drug Development
Neoleukin Therapeutics Announces Preclinical Data for NL-201 at American Association for Cancer Research (AACR) Annual Meeting
April 13, 2022
 · 
5 min read
Drug Development
Allogene Therapeutics Publishes Preclinical Data on ALLO-316, an AlloCAR T™ Candidate Targeting CD70 for the Treatment of Renal Cell Carcinoma, at AACR’s Annual Meeting and in Cancer Research Journal
April 13, 2022
 · 
4 min read
Drug Development
NeoImmuneTech Demonstrates NT-I7’s Broad Combination Potential with Immune Checkpoint Inhibitors and Immunocytokine at AACR 2022
April 13, 2022
 · 
4 min read
Drug Development
Basilea reports preclinical data on oncology drug candidates BAL0891, derazantinib and lisavanbulin at AACR Annual Meeting
April 13, 2022
 · 
13 min read
Drug Development
ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting
April 12, 2022
 · 
7 min read
Drug Development
Gain Therapeutics Presents Positive Data on its Small Molecule Lead Compound in GBA1 Parkinson’s Disease at the 2022 Synuclein Meeting
April 12, 2022
 · 
5 min read
Drug Development
Rakovina Therapeutics Presents Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research (AACR) Annual General Meeting
April 12, 2022
 · 
5 min read
Drug Development
LIXTE Biotechnology Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations
April 12, 2022
 · 
4 min read
Drug Development
Hoth Therapeutics Announces Acceptance to Present HT-ALZ Proof-of-Concept Alzheimer’s Disease Data at the 2022 Alzheimer’s Association International Conference
April 12, 2022
 · 
4 min read
Drug Development
APVO442 Prostate Cancer Data Presented at the American Association for Cancer Research Annual Meeting
April 12, 2022
 · 
6 min read
Drug Development
OncoNano Medicine Announces Positive Preclinical Data for Tumor Specific Delivery with the ON-BOARD™ Platform at AACR 2022 Annual Meeting
April 12, 2022
 · 
2 min read
Drug Development
Harpoon Therapeutics Presents Preclinical Data for TriTAC-XR Platform that Supports Potential for Improved Safety by Minimizing Cytokine Release Syndrome
April 12, 2022
 · 
6 min read
Drug Development
Schrödinger Reports New Preclinical Data Supporting Advancement of Its Wee1 Inhibitor Program at American Association of Cancer Research 2022 Annual Meeting
April 12, 2022
 · 
6 min read
Drug Development
ZielBio to Present New Data Demonstrating Preclinical Efficacy of ZB131 in Cholangiocarcinoma at AACR Annual Meeting 2022
April 12, 2022
 · 
3 min read
Drug Development
Cyclacel Pharmaceuticals Announces Publication Confirming Fadraciclib Suppresses MCL1 and Synergizes With Venetoclax in Chronic Lymphocytic Leukemia
April 12, 2022
 · 
9 min read
Load More